Next Generation Therapies

Scientific Council Member Husseini Manji, MD
Husseini Manji, MD
December 07, 2011

Scientific Council Member Husseini Manji, MD, was quoted in Nature Magazine on the closing of a brain research facility of Novartis, an international pharmaceutical company. The facility aimed to discover new drug...

Aaron Beck, M.D.
Aaron Beck, M.D.
November 15, 2011

Recent Foundation-funded research led by NARSAD Distinguished Investigator Grantee Aaron Beck, M.D. at the University of Pennsylvania, demonstrates that a targeted form of cognitive therapy can improve psychosocial and...

Allan T. Gulledge, Ph.D. of Dartmouth Medical School
Allan T. Gulledge, Ph.D.
November 15, 2011

The chemicals that act in the brain act in other parts of the body as well─in the heart, in the respiratory system, in muscles. Drugs that affect brain chemicals can therefore cause unwanted side effects in other body...

Keming Gao, M.D., Ph.D. of Case Medical Center
Keming Gao, M.D., Ph.D.
November 15, 2011

For people with mood disorders such as bipolar disorder or major depressive disorder─complex, heterogeneous illnesses on their own─having other brain and behavior disorders at the same time is the rule rather than the...

Jennifer Gottlieb, Ph.D., NARSAD YI, Dartmouth Medical School
Jennifer Gottlieb, Ph.D.
November 15, 2011

Upwards of half of people taking antipsychotic medications continue to have some symptoms of psychosis. Cognitive behavioral therapy (CBT) is a non-pharmaceutical intervention that helps people develop skills for coping...

Pages

Subscribe to